FibroBiologics begins patient enrollment for diabetic foot ulcer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to FibroBiologics begins patient enrollment for diabetic foot ulcer trial
(NASDAQ: FBLG) Delayed: 0.78 -0.03 (3.7%)
Previous Close $0.81    52 Week High $ 
Open $0.82    52 Week Low $ 
Day High $0.84    P/E N/A 
Day Low $0.78    EPS $ 
Volume 73,053